Copresentation of Tumor Antigens and Costimulatory Molecules via Biomimetic Nanoparticles for Effective Cancer Immunotherapy
- 7 May 2020
- journal article
- research article
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 20 (6), 4084-4094
- https://doi.org/10.1021/acs.nanolett.9b05171
Abstract
Nanoparticle (NP)-based cancer immunotherapy has been extensively explored. However, the efficacy of existing strategies is often limited by the lack of effective tumor-specific antigens or the inability to present costimulatory signal or both. Here, we report a novel approach to overcoming these limitations through surface coating with dendritic-tumor fusion cell membranes, which present whole repertories of tumor-associated antigens in the presence of costimulatory molecules. Because antigen-presenting and co-stimulatory molecules are displayed on their surface, these NPs can efficiently penetrate immune organs and activate T cells. We show that these NPs can be utilized to prevent tumor development and regress established tumors, including tumors in the brain. We demonstrate that encapsulation of immune adjuvants further improves their efficacy. Due to their significant efficacy, the whole tumor antigen-presenting co-stimulatory NPs have the potential to be translated into clinical applications for treatment of various cancers.Keywords
Funding Information
- National Institute of Neurological Disorders and Stroke (NS095817, NS110721)
- State of Connecticut
This publication has 42 references indexed in Scilit:
- PLGA-based nanoparticles: An overview of biomedical applicationsJournal of Controlled Release, 2012
- Octa-functional PLGA nanoparticles for targeted and efficient siRNA delivery to tumorsBiomaterials, 2012
- Dendritic cell–tumor cell hybrids and immunotherapy: what's next?Cytotherapy, 2011
- Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platformProceedings of the National Academy of Sciences of the United States of America, 2011
- Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responsesNature Materials, 2011
- Therapeutic cell engineering with surface-conjugated synthetic nanoparticlesNature Medicine, 2010
- Tumour-dendritic hybrid cell vaccination for the treatment of patients with malignant melanoma: immunological effects and clinical resultsVaccine, 2005
- Immunotherapy: past, present and futureNature Medicine, 2003
- An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrowJournal of Immunological Methods, 1999
- Induction of antigen-specific antitumor immunity with adenovirus-transduced dendritic cellsGene Therapy, 1997